RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response
Pigment Cell & Melanoma Research · 2024
DOI: 10.1111/pcmr.13170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2024. Verfasst von Yanhong Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Ocean and Tropical Medicine, The Second Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China. Hauptthemen laut MEDLINE: Melanoma, Tumor Microenvironment, Skin Neoplasms, Immunotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Key Laboratory of High-Incidence-Tumor Prevention and Treatment, National Natural Science Foundation of China, Ministry of Education People's Republic of China.
Abstract (Originalsprache)
Recent years have seen rising mortality rates linked to cutaneous melanoma (SKCM), despite advances in immunotherapy. Understanding RNA N6‐methyladenosine (M6A) significance in SKCM is crucial for prognosis, tumor microenvironment (TME), immune cell presence, and immunotherapy efficacy. We analyzed 23 M6A regulators using SKCM samples from TCGA and GEO databases, identifying three M6A modification patterns linked to TME cell infiltration. Principal component analysis (PCA) yielded an M6A score for individual tumors, utilizing patient gene expression profiles and CNV data from TCGA. M6A modification patterns play a crucial role in SKCM development and progression, influencing tumor attributes such as inflammatory stage, subtype, TME interstitial activity, and genetic mutations. The M6A score independently predicts patient outcomes and correlates with improved response to immunotherapy, validated across anti‐PD‐1 and anti‐PD‐L1 therapy cohorts. M6A modifications significantly impact the TME landscape, with the M6A score serving as a predictive marker for immunotherapy response. Integrating M6A‐related information into clinical practice could revolutionize SKCM management and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Ocean and Tropical Medicine, The Second Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China.
- Liuzhou Key Laboratory of Molecular Diagnosis, Guangxi Health Commission Key Laboratory of Molecular Diagnosis and Application, Affiliated Liutie Central Hospital of Guangxi Medical University, Liuzhou, China.
ORCID-Profile: Xiao Zhu
Förderung
- Key Laboratory of High-Incidence-Tumor Prevention and Treatment
- National Natural Science Foundation of China
- Ministry of Education People's Republic of China
- Guangxi Science and Technology Program
Zitieren
APA
Wu, Y., He, H., Zheng, K., Qin, Z., Cai, N., Zuo, S., & Zhu, X. (2024). RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13170
Vancouver
Wu Y, He H, Zheng K, Qin Z, Cai N, Zuo S, et al. RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response. Pigment Cell & Melanoma Research. 2024. doi:10.1111/pcmr.13170
BibTeX
@article{Wu2024,
author = {Wu, Yanhong and He, Hongying and Zheng, Kairong and Qin, Zhenxin and Cai, Naikun and Zuo, Shuguang and Zhu, Xiao},
title = {RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response},
journal = {Pigment Cell & Melanoma Research},
year = {2024},
doi = {10.1111/pcmr.13170}
}
EUVIMED